Novo Nordisk
NVO
#96
Rank
NZ$334.41 B
Marketcap
NZ$75.46
Share price
0.81%
Change (1 day)
-36.28%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

ESG Reports

Thumbnail Novo Nordisk ESG Report 2024

ESG Report 2024

Language: English

View ESG Report